Bruce G. Redman

University of Michigan

Full Professor(heuristic)

Renal cell carcinoma treatment · Pulmonary and Respiratory Medicine

h-index56

i10-index108

Publications195

Citations14,468

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last latest available · showing 18 of 18

Supplementary Figure 4 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 6 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 1 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure Legend from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 2 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 3 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 5 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure Legend from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 6 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 5 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 3 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Tables from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas
2023-03-31
Supplementary Figure 4 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 1 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Figure 2 from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Data from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Data from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell CarcinomasPreprint
2023-03-31
Supplementary Tables from Phase I Trials of Anti-ENPP3 Antibody–Drug Conjugates in Advanced Refractory Renal Cell Carcinomas
2023-03-31

Open author page on OpenAlex →